WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Domain Name Industry Saturday, May 9, 2026 
Add Press Release News | News Feeds Feeds | Email This News Email


NLP Leader Huma.AI Launches Industry's First Generative AI Platform for Life Sciences
Tuesday, February 14, 2023

Enterprise Generative AI Focused on Life Sciences to Bring Life-Saving Drugs to Market Faster

PALO ALTO, Calif., Feb. 6, 2023 /PRNewswire-PRWeb/ -- Huma.AI, a leading healthcare AI company, announced today the launch of its industry-first AI platform for life sciences, which is designed to accelerate the development of life-saving drugs through better usage of their data.

Historically, it has taken 10 years and approximately $2.6 billion to develop a new drug, with a 95% failure rate. This is primarily because 80% of the healthcare/life science data is text-based (unstructured) and siloed in 90-100 disparate data sources. The industry primarily relies on manual curation of data, leaving many critical questions unanswered.

Huma.AI's natural language processing (NLP) platform replaces and automates such manual curation. It connects and searches multiple, disparate, unstructured data sources, returning answers to questions in seconds.

Huma.AI's industry-first generative AI platform for enterprises leverages existing large language models to surface previously unknown intelligence. Going beyond ChatGPT, it analyzes private enterprise data from multiple sources and its "expert-in-the-loop" approach leads to the highest accuracy possible. Use cases include medical affairs (tell me what I don't know), clinical development (better trial design), post market surveillance (systematic literature review and state-of-the-art appraisal) and real-world evidence (patient journey).

"ChatGPT is one of the fastest adopted AI tool in history. It is incredibly useful for general purpose, but not yet adequate at handling complex life science data. We have been working with OpenAI for quite some time to address that," said Huma.AI co-founder and CEO Lana Feng, Ph.D., who previously worked at Novartis Oncology Business Unit to establish international partnerships for their precision medicine programs. She joined Novartis through its acquisition of Genoptix where she built its BioPharma division from zero to $45 million in five years by creating alliances with pharmaceutical companies and providing companion diagnostics development for targeted cancer therapies.

"Huma.AI starts where ChatGPT ends," said Greg Kostello, co-founder and CTO of Huma.AI and author of Huma.AI's NLP granted patent with 25 claims.

Kostello, whose experience also includes contributions to Apple Computer, was previously the CEO for a SaaS Platform used by Cisco, ESPN and NASA, managing petabytes of data. He boasts a 35-year career dedicated to architecting and managing technology systems that solve complex data and business problems. He also worked with video enabling technology at three startups, one acquired by Facebook, EVP of Technology at MP3.com, was President of VUNet Technologies, co-founded a startup acquired by Netscape, and was a team leader that built the core engine for Firefox.

Huma.AI's generative AI platform is highly accurate and validated by global pharmaceutical customers showing it has performed better than human experts.

Customers have commented: "We thought the analysis was written by an expert" and "We thought this kind of output from AI was a pipe dream."

Attached is a PDF documenting customer use cases.

Huma.AI will have a presence at the Clinical Operations Conference-SCOPE 2023 in Orlando, Florida from February 6-9, 2023. SCOPE Summit has driven innovation in clinical trials and digital health for 14 years.

About Huma.AI
Co-founded by Lana Feng Ph.D. and Greg Kostello, Huma.AI is a leading generative AI company offering a powerful and user-friendly NLP platform that turns life science domain experts into their own data scientists. The name Huma means human plus machine where humans always come first. Its transformative, human-centric AI platform has garnered tremendous industry recognition, and Huma.AI currently works with many pharmaceutical and medical device and IVD companies across the globe. Learn more at https://huma.ai.
###

Media Contact

Frank Tortorici, Marketing Maven Public Relations, Inc., 19088758908, frank@marketingmaven.com

SOURCE Huma.AI



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
Nav Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
Nav DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
Nav Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
Nav Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
Nav Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
Nav Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
Nav The Roadmap to Securing Your Own Digital Domain is Now Available | Jan 22, 2026
Nav Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
Nav Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News